Uutisia
Koska koronavirus SARS-CoV-2 ja sen aiheuttama COVID-19 sairaus ovat nyt ajankohtaisia, ohessa eri valmistajien tuoteuutisia.
IGG ja IgM Koronavirus-ELISA -kitit diagnostiikkaan CE (IVD)
Protokolla
genesig® Coronavirus
(COVID-19) CE IVD
United States Biological now offers the New Coronavirus (COVID-19) CE-IVD kit which exclusively detects only this outbreak strain.
COVID-19 CE-IVD Kit
Product features
- Rapid detection and exclusive to the COVID-19 strain
- Does not detect other related coronavirus strains
- High priming efficiency
- Accurate controls to confirm extraction, and assay validity
- Lyophilised components for ambient shipping
- Highly specific detection profile
The genesig Real-Time PCR COVID-19 (CE) is CE-IVD marked and intended for in vitro diagnostic use in Europe.
USBio Catalog/Product Name
532222 genesig Real-Time PCR Detection Kit for Coronavirus (Strain 2019-nCoV), Easy
532223 ggenesig Real-Time PCR Detection Kit for Coronavirus (Strain 2019-nCoV), Standard
532224 genesig Real-Time PCR Detection Kit for Coronavirus (Strain 2019-nCoV), Advanced
Click here for a full listing of our various Coronavirus reagents:
Introducing Coronavirus Research Tools from BioVision
Coronaviruses are large, enveloped, non-segmented positive-sense RNA viruses that are known to affect humans, mammals and birds.
Recently scientists discovered a novel strain of Coronavirus that caused massive viral outbreak in China. This virus is more deadly than SARS-CoV and MERS-CoV combined, and is named as SARS-CoV-2 (previously, COVID-19). Due to limited information regarding the role of the SARS-CoV-2 proteins in viral pathogenesis and replication, not many treatment options are available. Additionally, there are limited research tools available in the market.
BioVision is pleased to announce the launch of Coronavirus antibodies, proteins, kits and anti-viral agents, the first in the market for Coronavirus research.These research products can detect SARS-CoV-2, SARS and MERS Coronaviruses.
Key Features:
- 1st in the Market
- Antibodies, Proteins, Kits & Anti-viral Agents Available
- Specific to SARS-CoV-2, SARS, MERS
A Closed-Tube, Diagnostic Test for COVID-19 at Home, Clinic, and Points of Entry
The 2019 novel coronavirus (COVID-19) epidemic is a growing public health emergency of international concern. As of February 25, 2020, the virus has spread to over 33 countries, sickened more than 80,000 people worldwide, and killed over 2,600 people. Current methods for qualitative detection of COVID-19 primarily depend on reverse transcription-PCR (RT-PCR). However, RT-PCR tests can produce false negative results due to insufficient detection sensitivity for patients with a low viral load. Moreover, RT-PCR requires well-equipped laboratories and skilled personnel. Due to the rapid spread of the virus and limited capacity of hospitals, a more accurate, rapid, and easy-to-use molecular diagnostic for COVID-19 is urgently needed.
In a recent preprint manuscript posted on ChemRxiv™, El-Tholoth and colleagues at the University of Pennsylvania have developed simple, point-of-care assays for qualitative COVID-19 detection using one-stage LAMP (loop-mediated isothermal amplification) or two-stage Penn-RAMP (recombinase polymerase amplification plus LAMP). Specificity was accomplished by amplifying a conserved sequence of ORF1ab from the COVID-19 genome with high homology to the virus and high divergence from all other coronaviruses. The one-stage LAMP assay contains an isothermal master mix with EvaGreen® dye for reliable and robust amplification. Results show the one-stage LAMP assay performs comparably to RT-PCR methods for COVID-19 detection in tests with purified template and mock patient samples. Results for the two-stage Penn-RAMP assay showed...
Full Citation
El-Tholoth, Mohamed; Bau, Haim H.; Song, Jinzhao (2020): A Single and Two-Stage, Closed-Tube,
El-Tholoth, Mohamed; Bau, Haim H.; Song, Jinzhao (2020): A Single and Two-Stage, Closed-Tube,
Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry. ChemRxiv. Preprint. https://doi.org/10.26434/chemrxiv.11860137.v1